NCT01204541
已完成
不适用
A Single-Center Pilot Study to Assess Macular Function
ORA, Inc.0 个研究点目标入组 24 人2010年9月
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Macular Degeneration
- 发起方
- ORA, Inc.
- 入组人数
- 24
- 状态
- 已完成
- 最后更新
- 14年前
概览
简要总结
This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.
研究者
入排标准
入选标准
- •Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
- •Subjects with early non-exudative age-related macular degeneration (AMD cohort)
排除标准
- •Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study
结局指标
主要结局
未指定
相似试验
Unknown
不适用
Long-Term Efficacy in AMD of Rheopheresis in North AmericaMacular DegenerationNCT00380172OccuLogix120
招募中
不适用
Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF InjectionsDry Eye SyndromesNCT06317922Francesco Bandello60
撤回
2 期
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)Dry Age-related Macular DegenerationGeographic AtrophyGene TherapyIntravitreal InjectionNCT04358471Hemera Biosciences
已完成
4 期
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to AfliberceptExudative Macular DegenerationNCT01617148Rishi Singh26
已完成
不适用
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual OcclusionDry EyeNCT04022382John C Meyer, MD17